Arch Venture Partners Xii, LLC

Number of records: 17
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
10-Jun-24 7:46 PM
View: 
Rapport Therapeutics, Inc. (RAPP) 10-Jun-24Conversion 3,728,740----100%
0 to 3.73M
20-Feb-24 5:38 PM
View: 
Prime Medicine, Inc. (PRME) 15-Feb-24Private Purchase
Duplicate
3,200,000$6.25$20,000,000.0026%
12.26M to 15.46M
12-Dec-23 7:53 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 08-Dec-23Acquisition (other)
Duplicate
1,879,650----6%
30.05M to 31.93M
15-Nov-23 6:54 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 14-Nov-23Purchase 3,357$11.98$40,216.90< 1%
4.13M to 4.13M
15-Nov-23 6:54 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 13-Nov-23Purchase 31,653$11.75$371,923.00< 1%
4.1M to 4.13M
13-Nov-23 7:00 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 10-Nov-23Purchase 17,275$11.49$198,481.00< 1%
4.08M to 4.1M
13-Nov-23 7:00 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 09-Nov-23Purchase 31,079$10.53$327,262.00< 1%
4.05M to 4.08M
13-Nov-23 7:00 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 08-Nov-23Purchase 92,251$11.03$1,017,820.002%
3.96M to 4.05M
07-Nov-23 6:59 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 07-Nov-23Purchase 30,192$11.50$347,208.00< 1%
3.93M to 3.96M
07-Nov-23 6:59 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 06-Nov-23Purchase 43,082$11.55$497,597.001%
3.88M to 3.93M
07-Nov-23 6:59 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 03-Nov-23Purchase 22,420$11.38$255,140.00< 1%
3.86M to 3.88M
29-Sep-23 6:53 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 29-Sep-23Purchase 34,560$13.98$483,149.00< 1%
3.83M to 3.86M
29-Sep-23 6:53 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 28-Sep-23Purchase 41,951$13.44$563,699.001%
3.78M to 3.83M
27-Sep-23 8:18 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 27-Sep-23Purchase 24,504$12.31$301,644.00< 1%
3.76M to 3.78M
27-Sep-23 8:18 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 26-Sep-23Purchase 34,000$11.73$398,820.00< 1%
3.72M to 3.76M
25-Sep-23 9:38 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 25-Sep-23Purchase
Duplicate
60,740$11.22$681,464.002%
3.66M to 3.72M
25-Sep-23 9:38 PM
View: 
Neumora Therapeutics, Inc. (NMRA) 22-Sep-23Purchase
Duplicate
40,000$11.14$445,600.001%
3.62M to 3.66M